Status:
UNKNOWN
Renal Denervation in Patients After Acute Coronary Syndrome
Lead Sponsor:
Meshalkin Research Institute of Pathology of Circulation
Conditions:
Acute Coronary Syndrome
Arterial Hypertension
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
This study is aimed to evaluate the effect of renal denervation to decreasing blood pressure and left ventricle remodeling progression in patients after acute coronary syndrome.
Eligibility Criteria
Inclusion
- acute Q negative myocardium infarction (during first 14 days)
- non stable angina
- significant stenosis
- BP \> 140/90 torr. during more than 1 year
Exclusion
- absence of arterial hypertension
- Thrombolysis during previous 24 hours
- indications for CABG
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2016
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01901549
Start Date
June 1 2013
End Date
June 1 2016
Last Update
September 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
State Research Institute of Circulation Pathology
Novosibirsk, Russia, 630055